David Fuller

Technik-/Wissenschafts-/F&E-Leiter bei DIMERIX LIMITED

Vermögen: 1 548 $ am 30.04.2024

Health Technology

Aktive Positionen von David Fuller

Unternehmen	Position	Beginn	Ende
ADALTA LIMITED	Direktor/Vorstandsmitglied	22.07.2020	-
DIMERIX LIMITED	Technik-/Wissenschafts-/F&E-Leiter	23.10.2023	-
EpiAxis Therapeutics Pty Ltd. EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology EpiAxis Therapeutics Pty Ltd. engages in biotechnology company. It pursuing a preclinical and clinical drug development program directed at the prevention of metastatic disease by targeting the pivotal enzyme system controlling the proliferation of cancer stem cells. The company was founded by Jeremy Chrisp and Sudha Rao and is headquartered in Canberra, Australia.	Vorsitzender	-	-

Unternehmen	Position	Beginn	Ende
RACE ONCOLOGY LIMITED	Technik-/Wissenschafts-/F&E-Leiter	01.07.2021	11.11.2022

International

Australien

Operativ

Sektoral

Health Technology

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	3
DIMERIX LIMITED	Health Technology
ADALTA LIMITED	Health Technology
RACE ONCOLOGY LIMITED	Health Technology

Private Unternehmen	1
EpiAxis Therapeutics Pty Ltd. EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology EpiAxis Therapeutics Pty Ltd. engages in biotechnology company. It pursuing a preclinical and clinical drug development program directed at the prevention of metastatic disease by targeting the pivotal enzyme system controlling the proliferation of cancer stem cells. The company was founded by Jeremy Chrisp and Sudha Rao and is headquartered in Canberra, Australia.	Health Technology

Private Unternehmen

Health Technology